XML 31 R20.htm IDEA: XBRL DOCUMENT v3.5.0.2
Stockholders’ Equity (Tables)
9 Months Ended
Sep. 30, 2016
Stockholders' Equity  
Schedule of stock-based compensation expense recognized by award type

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Nine months ended

 

 

September 30, 

 

September 30, 

 

 

2015

 

2016

    

2015

    

2016

Options awards

    

$

1,214,856

    

$

532,381

    

$

3,776,013

    

$

2,192,085

Restricted stock awards

 

 

196,875

 

 

(561,094)

 

 

549,562

 

 

(728,438)

Total stock-based compensation expense

 

$

1,411,731

 

$

(28,713)

 

$

4,325,575

 

$

1,463,647

 

Schedule of total compensation cost recognized for all stock-based compensation awards in the statements of operations

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Nine months ended

 

 

September 30, 

 

September 30, 

 

    

2015

    

2016

    

2015

    

2016

Research and development

    

$

385,376

    

$

22,112

 

$

1,202,335

 

$

86,751

General and administrative

 

 

1,026,355

 

 

(50,825)

 

 

3,123,240

 

 

1,376,896

Total stock-based compensation expense

 

$

1,411,731

 

$

(28,713)

 

$

4,325,575

 

$

1,463,647

 

Summary of activity for all options

 

 

 

 

 

 

 

 

 

 

 

 

 

    

 

    

 

 

    

 

    

 

 

 

 

 

 

 

Weighted Average

 

Weighted Average

 

Aggregate

 

 

 

 

 

Exercise Price

 

Contractual

 

Intrinsic

 

 

 

Shares

 

Per Share

 

Life (In Years)

 

Value

 

Outstanding—December 31, 2015

 

4,020,783

 

$

5.48

 

7.8

 

$

 —

 

Granted

 

 —

 

 

 —

 

 

 

 

 

 

Exercised

 

 —

 

 

 —

 

 

 

 

 

 

Forfeited

 

(1,652,793)

 

 

5.91

 

 

 

 

 

 

Outstanding—September 30, 2016

 

2,367,990

 

$

5.18

 

6.6

 

$

 —

 

Vested and expected to vest—September 30, 2016

 

2,363,144

 

$

5.18

 

6.6

 

$

 —

 

Exercisable at September 30, 2016

 

2,024,758

 

$

5.14

 

6.5

 

$

 —

 

 

Schedule of warrants outstanding to purchase shares of the entity's common stock

 

 

 

 

 

 

 

 

 

 

 

 

    

    

    

Number of

    

    

 

    

                                                                 

 

 

 

 

 

Shares

 

Exercise

 

 

 

Warrant Series

 

Underlying Equity Security

 

Issuable

 

Price

 

Expiration Date

 

2007 Warrant

 

common stock

 

1,961

 

$

7.65

 

May 2017

 

2009/2010 Warrants

 

common stock

 

52,815

 

$

0.85

 

November 2019-March 2020